Table 1

Baseline characteristics of patients with different outcome

Patients with a recurrent strokePatients without a recurrent strokeP value
No., n736
Age, years44.71±14.5647.72±11.800.527
Male, n (%)5 (71.43%)23 (63.89%)1.000*
Time from symptom onset, days23.00±13.4935.86±21.540.443
Stroke as quantifying event, n7 (100%)25 (69.44%)0.060
Hypoperfusion volume 1.5 s, mL67.67±52.2248.41±41.420.2920
Hypoperfusion volume 2.5 s, mL47.91±56.7612.54±23.780.0027
HVR, %53.17±29.8216.9±15.570.0002
HVR severity, n (%)0.008*
 0%–50%3 (42.86%)33 (91.67%)
 ≥50% (severe HVR)4 (57.14%)3 (8.33%)
Plaque assessment
Plaque enhancement, n (%)0.292
 Grade 01 (14.29%)5 (13.39%)
 Grade 11 (14.29%)16 (44.44%)
 Grade 25 (71.42%)15 (41.67%)
Plaque areas, mm2 6.40±2.854.95±3.130.344
Remodelling index1.01±0.230.96±0.300.519
Plaque burden, %57.79±11.8355.66±14.150.427
Plaque length, mm9.43±2.518.61±3.230.429
Risk factors
 Hypertension, n (%)3 (42.86%)28 (77.78%)0.081*
 Diabetes, n (%)0 (0%)10 (27.78%)0.172*
Coronary artery disease, n (%)0 (0%)3 (8.33%)1.000*
 Hyperlipidemia, n (%)7 (100%)29 (80.56%)0.577*
 Smoking, n (%)5 (71.43%)12 (33.33%)0.093*
 Obesity, n (%)0 (0%)0 (0%)1.000*
  • *Fisher’s exact test.

  • HVR, hypoperfusion volume ratio.